We are live on
!
Find out more
Oragenics
OGEN
OGEN
12 hedge funds and large institutions have $3.99M invested in Oragenics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more capital invested
Capital invested by funds: $2.39M → $3.99M (+$1.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
14% less funds holding
Funds holding: 14 → 12 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
3
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$184K |
| 2 |
Barclays
London,
United Kingdom
|
-$87.4K |
| 3 |
Renaissance Technologies
New York
|
-$76K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$35.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18K |